SCHEMBL5402993

SCHEMBL5402993

COc1ccc(CCN(CCC(=O)O)C(=O)c2ccccc2-c2ccccc2C(=O)N(C)c2cccnc2)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 2/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RAF1 P04049 1/20 0.41
MAP2K1 Q02750 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
KMT2A Q03164 1/20 0.41
SMPD1 P17405 1/20 0.41
LPAR1 Q92633 1/20 0.41
CYP51A1 Q16850 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
MAPT P10636 1/20 0.40
F2 P00734 1/20 0.40
F10 P00742 1/20 0.40
F7 P08709 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 2/20 0.40
GALR3 O60755 1/20 0.40
NR2F2 P24468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926471 0.94 POLB (0.45) MAPK1ALDH1A1HTTNPSR1RAF1
SCHEMBL4930232 0.94 POLB (0.41) MAPK1ALDH1A1HTTNPSR1RAF1
SCHEMBL5412105 0.89 TRPV1 (0.46) ALDH1A1TRPV1KMT2ALPAR1KDM4E
SCHEMBL5403373 0.88 ABCB1 (0.43) HTTTRPV1LPAR1RAB9A
SCHEMBL4930701 0.88 TRPV1 (0.41) MAPK1ALDH1A1NPSR1TRPV1LPAR1
SCHEMBL5409148 0.87 TRPV1 (0.48) ALDH1A1HTTTRPV1KMT2A
SCHEMBL5392395 0.87 NOTUM (0.40) MAPK1ALDH1A1TRPV1KMT2ALPAR1
SCHEMBL4930149 0.87 SGMS2 (0.44) MAPK1ALDH1A1NPSR1TRPV1KMT2A
SCHEMBL5412150 0.86 TBXAS1 (0.46) HTTTRPV1KMT2A
Hydrochloric Acid SCHEMBL1192158 0.86 SGMS2 (0.44) MAPK1ALDH1A1NPSR1TRPV1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB MAPK1 1369/4885ALDH1A1 1256/4885HTT 3791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.